Jul 17, 2018 · Hua-Jun He, Kenneth D. Cole. Plasma cell-free DNA is being widely explored as a biomarker for clinical screening. Currently, methods are optimized for the extraction and detection of double.

Hua-Jun HE, Biologist | Cited by 1,258 | of National Institute of Standards and Technology (NIST) | Read 57 publications | Contact Hua-Jun HE

The detection of cancer biomarkers in body fluids, referred to as "Liquid Biopsy", has become a cutting-edge technology that has the potential to non-invasively screen and diagnose cancer at early stage, monitor tumor progression, and evaluate therapy responses.

Hua-Jun He is a principal investigator of the Early Detection Research Network.

Jun Hua Lab - Lab Website. Dr. Hua's research has centered on the development of novel MRI technologies for in vivo functional and physiological imaging in the brain, and the application of such methods for studies in healthy and diseased brains.

He, Ms. Almeida, Dr. Choquette, Dr. Lund and Dr. Cole has produced the first of a new generation of diagnostic standards based on DNA from cancerous cells.

Hua-Jun He via Scopus - Elsevier Fusion and expression of the gene encoding human Mn-SOD to anti-CEA single-chain antibody in Escherichia coli Sheng wu gong cheng xue bao = Chinese journal of biotechnology

Articles by Hua-Jun He on Muck Rack. Find Hua-Jun He's email address, contact information, LinkedIn, Twitter, other social media and more.

Semantic Scholar profile for Hua‐Jun He, with 28 highly influential citations and 53 scientific research papers.

Feb 1, 2018 · We compared different methods (absorbance, fluorescent dye-binding, and digital PCR) for measuring the concentrations of human genomic DNA from cultured cells and absorbance measurements of a synthetic DNA oligonucleotide.